Back to search resultsSummaryRMgm-4426
|
||||||||
*RMgm-4426| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene tagging |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 29487181 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. yoelii |
| Parent strain/line | P. y. yoelii 17XNL |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Liang X, Lindner SE, Cui L |
| Name Group/Department | Department of Entomology |
| Name Institute | Pennsylvania State University |
| City | University Park |
| Country | USA |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-4426 |
| Principal name | PyPuf3::GFP |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Nuclear, nucleolar location of GFP-tagged Puf3 in blood stages. |
| Gametocyte/Gamete | Not tested |
| Fertilization and ookinete | Not tested |
| Oocyst | Puf3 changed its localization in mosquito and liver stages from nucleolar to cytosolic puncta. After transmission of the transgenic parasite line to mosquitoes, PyPuf3::GFP was observed to be concentrated into banded foci in the developing oocysts. When sporozoites were dissected from the developing oocysts on day 10, PyPuf3::GFP was found in punctate foci of the oocyst sporozoites. The PyPuf3::GFP foci were not observed in mature salivary gland sporozoites. |
| Sporozoite | Puf3 changed its localization in mosquito and liver stages from nucleolar to cytosolic puncta. After transmission of the transgenic parasite line to mosquitoes, PyPuf3::GFP was observed to be concentrated into banded foci in the developing oocysts. When sporozoites were dissected from the developing oocysts on day 10, PyPuf3::GFP was found in punctate foci of the oocyst sporozoites. The PyPuf3::GFP foci were not observed in mature salivary gland sporozoites. |
| Liver stage | Puf3 changed its localization in mosquito and liver stages from nucleolar to cytosolic puncta. During mid-liver stage development (24 h), large foci containing PyPuf3::GFP were visible, and they were adjacent to DAPI stained DNA but had minimal overlap. However, in late (48 h) liver stage schizonts, PyPuf3::GFP expression was not detectable. |
| Additional remarks phenotype | Mutant/mutation Phenotype |
Tagged: Mutant parasite with a tagged gene| top of page | |||||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PY17X_1121600 | ||||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0621300 | ||||||||||||||||||||||||||
| Gene product | mRNA-binding protein PUF3 | ||||||||||||||||||||||||||
| Gene product: Alternative name | PUF3 | ||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||||
| Name of the tag | GFP | ||||||||||||||||||||||||||
| Details of tagging | C-terminal | ||||||||||||||||||||||||||
| Additional remarks: tagging | |||||||||||||||||||||||||||
| Commercial source of tag-antibodies | |||||||||||||||||||||||||||
| Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
| Promoter of the selectable marker | unknown | ||||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||||
| Additional remarks genetic modification | |||||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||